Or you could try navitoclax, dasatinib, fisetin, piperlongumine, or any of the others tested so far in animal models and human cancer trials with well-understood pharmacology and that are easily purchased.

The trick here is that the current state of assays for senescent cell presence in samples is pretty terrible if you're outside a lab, and there is little point in doing this without measuring the outcome.